We are live on ! Find out more
Caption Management

Caption Management Portfolio holdings

AUM $21.5B Turnover 58.11%
1-Year Est. Return 81.81%
 

Caption Management runs private funds that trade U.S. stocks and stock options, usually holding positions for two to four months. It looks for mispricings in stock and options markets through company research, and aims to profit from moves in share prices or in expected price swings. Jason Strasser and William Cooper, who both graduated from Duke University in 2007, started the firm in 2012 and own most of it. Strasser began his career as an equity derivatives trader at Morgan Stanley and then worked as an analyst at the hedge fund Trafelet & Company. Its funds are open to high net worth individuals, family offices, endowments, foundations and institutional investors.

This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$21.5B
AUM Growth
+$4.34B
Cap. Flow
+$423M
Cap. Flow %
1.97%
Top 10 Hldgs %
19.17%
Holding
2,170
New
686
Increased
353
Reduced
351
Closed
575
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.4 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.42%
2 Technology 5.01%
3 Healthcare 1.9%
4 Consumer Discretionary 1.75%
5 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EZPW icon
926
Ezcorp Inc
EZPW
$1.77B
$1.87M 0.01%
54,000
+25,000
+86% +$789K
2025 Q1
5 quarters
CABA icon
927
CALL
Cabaletta Bio
CABA
$241M
$1.86M 0.01%
599,500
+499,500
+500% +$1.64M
2026 Q1
1 quarter
BNTX icon
928
CALL
BioNTech
BNTX
$21.8B
$1.86M 0.01%
+20,000
New +$1.88M
2026 Q2
0 quarters
AGIO icon
929
CALL
Agios Pharmaceuticals
AGIO
$1.86B
$1.86M 0.01%
+50,000
New +$1.52M
2026 Q2
0 quarters
SLS icon
930
PUT
SELLAS Life Sciences
SLS
$1.79B
$1.84M 0.01%
+125,000
New +$863K
2026 Q2
0 quarters
TENB icon
931
CALL
Tenable Holdings
TENB
$4.93B
$1.84M 0.01%
+50,000
New +$1.18M
2026 Q2
0 quarters
CXW icon
932
CoreCivic
CXW
$3.06B
$1.84M 0.01%
+60,578
New +$1.37M
2026 Q2
0 quarters
BIOA icon
933
CALL
BioAge Labs
BIOA
$274M
$1.84M 0.01%
+75,000
New +$1.35M
2026 Q2
0 quarters
GPRE icon
934
CALL
Green Plains
GPRE
$986M
$1.83M 0.01%
119,000
– –
2025 Q4
2 quarters
NKTR icon
935
PUT
Nektar Therapeutics
NKTR
$1.29B
$1.82M 0.01%
26,100
-123,900
-83% -$9.07M
2025 Q3
3 quarters
NNDM icon
936
CALL
Nano Dimension
NNDM
$287M
$1.81M 0.01%
1,250,000
-825,300
-40% -$1.35M
2026 Q1
1 quarter
MARA icon
937
Marathon Digital Holdings
MARA
$2.77B
$1.81M 0.01%
130,000
-265,981
-67% -$3.33M
2026 Q1
1 quarter
ATEX icon
938
Anterix
ATEX
$1.61B
$1.8M 0.01%
+17,532
New +$1.03M
2026 Q2
0 quarters
SLN icon
939
Silence Therapeutics
SLN
$1.23B
$1.78M 0.01%
+162,476
New +$1.14M
2026 Q2
0 quarters
GAP icon
940
The Gap Inc
GAP
$7.72B
$1.78M 0.01%
95,401
+63,101
+195% +$1.45M
2025 Q3
3 quarters
DRAM icon
941
Roundhill Memory ETF
DRAM
$22.4B
$1.77M 0.01%
+24,000
New +$1.25M
2026 Q2
0 quarters
FLG icon
942
PUT
Flagstar Bank National Association
FLG
$4.38B
$1.77M 0.01%
118,500
-390,000
-77% -$5.53M
2025 Q4
2 quarters
AB icon
943
CALL
AllianceBernstein
AB
$3.22B
$1.76M 0.01%
50,000
– –
2026 Q1
1 quarter
AR icon
944
Antero Resources
AR
$12.3B
$1.76M 0.01%
+50,000
New +$1.84M
2026 Q2
0 quarters
GDX icon
945
VanEck Gold Miners ETF
GDX
$23.9B
$1.74M 0.01%
23,100
+6,100
+36% +$539K
2025 Q3
3 quarters
BWA icon
946
BorgWarner
BWA
$10.4B
$1.74M 0.01%
+26,236
New +$1.66M
2026 Q2
0 quarters
GIS icon
947
General Mills
GIS
$18.2B
$1.74M 0.01%
+50,000
New +$1.73M
2026 Q2
0 quarters
HUT icon
948
Hut 8
HUT
$7.86B
$1.74M 0.01%
+15,051
New +$1.46M
2026 Q2
0 quarters
CAPR icon
949
Capricor Therapeutics
CAPR
$479M
$1.73M 0.01%
+72,000
New +$2.18M
2026 Q2
0 quarters
IE icon
950
PUT
Ivanhoe Electric
IE
$1.23B
$1.72M 0.01%
179,400
-120,200
-40% -$1.52M
2025 Q3
3 quarters

Similar funds

Caption Management's Q2 2026 Portfolio in Review

As of Q2 2026, Caption Management held 2,170 positions worth $21.5B, up 25% from $17.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Caption Management's Q2 2026 filing shows 686 new, 353 increased, 351 reduced and 575 closed positions. Its largest new stake was TSMC: 565,700 shares worth $270M. The largest sale was Meta Platforms (Facebook), an estimated $52.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Technology and Healthcare.

  • Caption Management's largest Q2 2026 buy was TSMC: 565,700 shares worth $270M.
  • Caption Management added most to Microsoft in Q2 2026, an estimated $198M increase.
  • Caption Management's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $52.2M.
  • Caption Management fully exited Planet Labs PBC Warrants in Q2 2026, selling an estimated $24.9M.
  • Caption Management's ten largest holdings make up 19% of its $21.5B portfolio in Q2 2026.
  • Caption Management opened 686 new positions and closed 575 in Q2 2026.
  • Caption Management's portfolio value rose 25% quarter-over-quarter to $21.5B.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.